These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20921205)

  • 1. Therapeutic potential of ketotifen in irritable bowel syndrome (IBS) may involve changes in mast cells at sites beyond the rectum.
    O'Sullivan M
    Gut; 2011 Mar; 60(3):423; author rpely 423. PubMed ID: 20921205
    [No Abstract]   [Full Text] [Related]  

  • 2. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome.
    Klooker TK; Braak B; Koopman KE; Welting O; Wouters MM; van der Heide S; Schemann M; Bischoff SC; van den Wijngaard RM; Boeckxstaens GE
    Gut; 2010 Sep; 59(9):1213-21. PubMed ID: 20650926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The irritable bowel syndrome, should not be considered a functional disorder?].
    Sebastián Domingo JJ
    Med Clin (Barc); 2013 May; 140(9):403-5. PubMed ID: 23337457
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical efficacy and safety of ketotifen in treating irritable bowel syndrome with diarrhea.
    Wang J; Wang Y; Zhou H; Gu W; Wang X; Yang J
    Eur J Gastroenterol Hepatol; 2020 Jun; 32(6):706-712. PubMed ID: 32317585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketotifen induced inhibition of histamine release in a non-IgE model of middle ear effusion.
    Berger G; Berger R; Goldberg A
    Pediatr Allergy Immunol; 2006 Feb; 17(1):43-8. PubMed ID: 16426254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome.
    Barbara G; Stanghellini V; Cremon C; De Giorgio R; Fronzoni L; Serra M; Corinaldesi R
    Dig Dis; 2009; 27 Suppl 1():115-21. PubMed ID: 20203507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral hypersensitivity in IBS: from bench to bedside.
    van Diest SA; Stanisor OI; de Jonge WJ; Boeckxstaens GE; van den Wijngaard RM
    J Pediatr Gastroenterol Nutr; 2011 Dec; 53 Suppl 2():S34-5. PubMed ID: 22235465
    [No Abstract]   [Full Text] [Related]  

  • 8. Mast cell stabilizer ketotifen [4-(1-methyl-4-piperidylidene)-4h-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one fumarate] prevents mucosal mast cell hyperplasia and intestinal dysmotility in experimental Trichinella spiralis inflammation in the rat.
    Serna H; Porras M; Vergara P
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1104-11. PubMed ID: 16988056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketotifen use in a patient with fire ant hypersensitivity and mast cell activation syndrome.
    Asawa A; Simpson KH; Bonds RS
    Ann Allergy Asthma Immunol; 2015 Jun; 114(6):443-6. PubMed ID: 25868710
    [No Abstract]   [Full Text] [Related]  

  • 10. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.
    Lee KJ; Kim YB; Kim JH; Kwon HC; Kim DK; Cho SW
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1689-94. PubMed ID: 19120860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of
    Burks CA; Rhodes SD; Bessler WK; Chen S; Smith A; Gehlhausen JR; Hawley ET; Jiang L; Li X; Yuan J; Lu Q; Jacobsen M; Sandusky GE; Jones DR; Clapp DW; Blakeley JO
    Mol Cancer Ther; 2019 Dec; 18(12):2321-2330. PubMed ID: 31527226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cells count and serum cytokine levels in patients with irritable bowel syndrome.
    Goral V; Kucukoner M; Buyukbayram H
    Hepatogastroenterology; 2010; 57(101):751-4. PubMed ID: 21033222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketotifen abrogates local and systemic consequences of rat intestinal ischemia-reperfusion injury.
    Kalia N; Brown NJ; Wood RF; Pockley AG
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1032-8. PubMed ID: 15955211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
    Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential responding of autonomic function to histamine H₁ antagonism in irritable bowel syndrome.
    Hattori T; Watanabe S; Kano M; Kanazawa M; Fukudo S
    Neurogastroenterol Motil; 2010 Dec; 22(12):1284-91, e335. PubMed ID: 20667004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abdominal Massage Improves the Symptoms of Irritable Bowel Syndrome by Regulating Mast Cells via the Trypase-PAR2-PKC
    Li H; Zhang W; Ma F; Zhang X; Wang Y; Wang J
    Pain Res Manag; 2022; 2022():8331439. PubMed ID: 36213180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketotifen fumarate attenuates feline gingivitis related with gingival microenvironment modulation.
    Yuan W; Hou S; Jia H; Qiu Z; Liu T; Chen X; Li H; Sun Y; Liang L; Sui X; Zhao X; Zhao Z
    Int Immunopharmacol; 2018 Dec; 65():159-173. PubMed ID: 30316074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medications and their use in the treatment of adverse reactions to foods.
    Sogn D
    J Allergy Clin Immunol; 1986 Jul; 78(1 Pt 2):238-43. PubMed ID: 2873162
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of mast cell stabilization in treatment of postoperative ileus: a pilot study.
    The FO; Buist MR; Lei A; Bennink RJ; Hofland J; van den Wijngaard RM; de Jonge WJ; Boeckxstaens GE
    Am J Gastroenterol; 2009 Sep; 104(9):2257-66. PubMed ID: 19491822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.